Yamazawa, Erika
Cahill, Daniel P.
Frosch, Matthew P.
Brastianos, Priscilla K.
Sullivan, Ryan J.
Funding for this research was provided by:
Merck
Replimune
Mirati
Eli Lilly
Kinnate
BMS
Marnego
Novartis
Pfizer
Article History
Received: 15 January 2025
Accepted: 25 February 2025
First Online: 12 March 2025
Declarations
:
: This research was approved by the Massachusetts General Hospital Institutional Review Board and all human participants involved in this work provided written consent prior to study commencement.
: Not applicable.
: The authors declare no competing interests.